Adrenal gland – CDH16 negative adrenocortical adenoma.
Adrenal gland - CDH16 negative adrenocortical adenoma. Esophagus – CDH16 negative adenocarcinoma.
Esophagus - CDH16 negative adenocarcinoma. Kidney – Chromophobe renal cell carcinoma with strong CDH16 immunostaining of tumor cells (CDH16 immunohistochemistry)
Kidney - Chromophobe renal cell carcinoma with strong CDH16 immunostaining of tumor cells (CDH16 immunohistochemistry)Kidney – Clear cell renal cell carcinoma with weak to moderate CDH16 staining of a fraction of tumor cells (CDH16 immunohistochemistry).
Kidney - Clear cell renal cell carcinoma with weak to moderate CDH16 staining of a fraction of tumor cells (CDH16 immunohistochemistry). Kidney – Oncocytoma with strong CDH16 immunostaining of tumor cells (CDH16 immunohistochemistry).
Kidney - Oncocytoma with strong CDH16 immunostaining of tumor cells (CDH16 immunohistochemistry). Kidney – Papillary renal cell carcinoma with weak CDH16 staining of most tumor cells (CDH16 immunohistochemistry).
Kidney - Papillary renal cell carcinoma with weak CDH16 staining of most tumor cells (CDH16 immunohistochemistry).Liver – CDH16 negative hepatocellular carcinoma.
Liver - CDH16 negative hepatocellular carcinoma. Lung – CDH16 negative adenocarcinoma.
Lung - CDH16 negative adenocarcinoma.Lung – CDH16 negative small cell carcinoma.
Lung - CDH16 negative small cell carcinoma. Lung – CDH16 negative squamous cell carcinoma.
Lung - CDH16 negative squamous cell carcinoma.Lung – Neuroendocrine tumor showing strong CDH16 staining of tumor cells (CDH16 immunohistochemistry).
Lung - Neuroendocrine tumor showing strong CDH16 staining of tumor cells (CDH16 immunohistochemistry).Lymph node – CDH16 negative Hodgkin’s lymphoma.
Lymph node - CDH16 negative Hodgkin’s lymphoma.Oral cavity – CDH16 negative squamous cell carcinoma.
Oral cavity - CDH16 negative squamous cell carcinoma. Ovary – CDH16 negative serous high-grade carcinoma.
Ovary - CDH16 negative serous high-grade carcinoma.Ovary – Clear cell carcinoma with strong CDH16 immunostaining of tumor cells (CDH16 immunohistochemistry).
Ovary - Clear cell carcinoma with strong CDH16 immunostaining of tumor cells (CDH16 immunohistochemistry). Ovary – Endometroid carcinoma with strong CDH16 immunostaining of tumor cells (CDH16 immunohistochemistry).
Ovary - Endometroid carcinoma with strong CDH16 immunostaining of tumor cells (CDH16 immunohistochemistry). Pancreas – CDH16 negative neuroendocrine tumor.
Pancreas - CDH16 negative neuroendocrine tumor. Pancreas – Neuroendocrine tumor with moderate to strong CDH16 positivity of tumor cells (CDH16 immunohistochemistry)
Pancreas - Neuroendocrine tumor with moderate to strong CDH16 positivity of tumor cells (CDH16 immunohistochemistry)Prostate – CDH16 negative adenocarcinoma (Gleason 3+3=6)
Prostate - CDH16 negative adenocarcinoma (Gleason 3+3=6)Salivary gland – CDH16 negative Warthin tumor.
Salivary gland - CDH16 negative Warthin tumor. Soft tissue – CDH16 negative leiomyosarcoma.
Soft tissue - CDH16 negative leiomyosarcoma. Soft tissue – CDH16 negative liposarcoma.
Soft tissue - CDH16 negative liposarcoma. Stomach – CDH16 negative adenocarcinoma.
Stomach - CDH16 negative adenocarcinoma. Stomach – CDH16 negative gastrointestinal stromal tumor (GIST).
Stomach - CDH16 negative gastrointestinal stromal tumor (GIST). Testis – CDH16 negative seminoma
Testis - CDH16 negative seminomaThyroid – CDH16 negative medullary carcinoma.
Thyroid - CDH16 negative medullary carcinoma. Thyroid – CDH16 negative papillary carcinoma invading CDH16 positive normal thyroid (CDH16 immunohistochemistry)
Thyroid - CDH16 negative papillary carcinoma invading CDH16 positive normal thyroid (CDH16 immunohistochemistry)Thyroid – CDH16 staining is lacking in a papillary thyroid carcinoma but clearly visible in adjacent normal thyroid (CDH16 immunohistochemistry).
Thyroid - CDH16 staining is lacking in a papillary thyroid carcinoma but clearly visible in adjacent normal thyroid (CDH16 immunohistochemistry). Thyroid – Complete lack of CDH16 staining in a follicular carcinoma (CDH16 immunohistochemistry)
Thyroid - Complete lack of CDH16 staining in a follicular carcinoma (CDH16 immunohistochemistry)Thyroid – Complete lack of CDH16 staining in a papillary carcinoma (CDH16 immunohistochemistry).
Thyroid - Complete lack of CDH16 staining in a papillary carcinoma (CDH16 immunohistochemistry). Thyroid – Follicular adenoma with strong CDH16 immunostaining of tumor cells (CDH16 immunohistochemistry).
Thyroid - Follicular adenoma with strong CDH16 immunostaining of tumor cells (CDH16 immunohistochemistry). Urinary bladder – CDH16 negative muscle-invasive urothelial carcinoma.
Urinary bladder - CDH16 negative muscle-invasive urothelial carcinoma. Uterus – Endometroid endometrium carcinoma with weak to moderate CDH16 immunostaining of the majority of tumor cells (CDH16 immunohistochemistry).
Uterus - Endometroid endometrium carcinoma with weak to moderate CDH16 immunostaining of the majority of tumor cells (CDH16 immunohistochemistry). Uterus, cervix – Adenocarcinoma with strong CDH16 staining in about 60_ of tumor cells (CDH16 immunohistochemistry).
Uterus, cervix - Adenocarcinoma with strong CDH16 staining in about 60_ of tumor cells (CDH16 immunohistochemistry).